Vitaforest Chaga Mushroom Native Dry Extract

Chaga Mushroom Native Dry Extract is a dry fine powder, brown-yellow to brown in color. It has a sweet-sour taste with characteristic odor. It is GMO-free, BSE/TSE-free and Allergen-free. It is used in cosmetics, food and drinks, pharmaceutical industry, feeds, food supplements and nutrition. It has an antispasmodic effect and protects liver cells from toxic damage. It has an immunomodulatory effect which increases the body's resistance to infectious diseases. It also possesses anti-inflammatory and diuretic properties.

Ingredient Name: Chaga Mushroom Extract

Functions: Anti-Microbial Agent, Dietary Supplement, Supplement, Whole Food Ingredient

Ingredient Origin: Natural Origin, Plant Origin

Labeling Claims: Allergen-free, BSE-free, GMO-free, Nanomaterials-free, Natural, Naturally Derived, Non-Toxic, Pesticide-free, Plant-Based, Preservative-free, TSE-free

    Knowde Enhanced TDS

    Identification & Functionality

    Chemical Family
    Ingredient Name
    Animal Feed & Nutrition Functions
    Pharma & Nutraceuticals Functions
    Ingredients
    Chaga Mushroom Extract
    Chemical Composition

    Chaga contains water-soluble pigments that form the chromogenic complex: pterins, as well as humic-like chaga acid (up to 60%), polysaccharides (6 to 8%), lignin, fiber, steroid, pteric compounds (6% to 8%), and 3 yarns acids, free phenols, salts of silicon, iron, aluminum, calcium, magnesium, sodium, zinc, copper, manganese, potassium.

    Features & Benefits

    Food Ingredients Features
    Product Background

    For a long time, chaga has been used as a remedy against internal tumors in traditional medicine. As the annals indicate, for this purpose it was used as early as the beginning of the twelfth century. Chaga treatment is mentioned in various books of the time. Chaga is widespread throughout the temperate zone of the Northern Hemisphere but does not reach the borders of the birch population range, especially the southern ones.

    Outgrowths are found not only on birch trees but also (less often) on alder, mountain ash, ash, elm, in the zone of mixed and deciduous temperate forests, in moderately humid forests and in moderately moist spruce forests with a mixture of birch. The best hosts of the fungus are birches.

    Features and Benefits
    • GMO Free
    • BSE/TSE free
    • Allergen free

    Applications & Uses

    Food & Nutrition Applications
    Applications

    Industry

    • Cosmetic
    • Pharmaceutical industry
    • Food supplements
    • Food and drinks
    • Feeds
    • Healthy nutrition

    Properties

    Physical Form
    Odor
    Characteristic
    Appearance
    Dark brown fine powder
    Typical Properties
    ValueUnitsTest Method / Conditions
    Arsenic Contentmax. 2ppmICP-MS
    Cadmium Contentmax. 1ppmICP-MS
    Heavy Metals Contentmax. 10ppmICP-MS
    Lead Contentmax. 3ppmICP-MS
    Mercury Contentmax. 0.1ppmICP-MS
    Polyphenol Contentmax. 6%UV Analysis
    Polysaccharides Contentmax. 25%UV Analysis
    Physico-Chemical Properties
    ValueUnitsTest Method / Conditions
    Ash Contentmax. 6%Ph.Eur./USP
    Bulk Density0.3-0.7g/mlPh.Eur./USP
    Loss of Dryingmax. 5%Ph.Eur./USP
    Microbiological Values
    ValueUnitsTest Method / Conditions
    Enterobacteriaceae Contentmax. 100CFU/gPh.Eur./USP
    Escherichia Coli Content1gmPh.Eur./USP
    Salmonella25gmPh.Eur./USP
    Total Plate Countmax. 5000CFU/gPh.Eur./USP
    Yeasts and Moldsmax. 500CFU/gPh.Eur./USP

    Regulatory & Compliance

    Statements
    • Non Irradiation/Non Ionized Statement
      We hereby certify that the product has not been sterilized byionizing radiation at anypoint during the entire manufacturing process and therefore is in full compliance with the relevant legislated regulations (Directive 1999/2/CE).
    • BSE/TSE Statement
      We hereby certify that the product contains no ingredients of ruminant origin and no materials derived from, or exposed to ruminants affected byor under quarantine for Transmitting Transmissible Spongiform Encephalopathy(TSE)/ Bovine Spongiform Encephalopathy (BSĖ) and it is conform to the EU legislation 999/2001.
    • Packaging Statement
      We hereby certify that the packing used is in compliance with: Commission Regulation (EC)No 1935/2004 and Regulation (EU) No 10/2011 regarding packaging materials and articles intended to come into contact with food.
    • Pesticide Statement
      We hereby certify, basis on our actual knowledge of production process, raw materials and equipment used potential pesticide residues in the above-mentioned product comply with the European legislation on pesticide residues, esp. Regulation (EC) No. 396/2005.
    • Residual Solvent Statement
      We hereby certify that the product meets with: Directive E 2010/59/EU of 26 August 2010 amending Directive 2009/32/EC ofthe European Parliamentand of the Council on the approximation of the laws of the Member States on extraction solvents used in the production of foodstuffs and food ingredients.
    • Contaminant Statement
      This is to certify that the product meets with:
      REGULATION (EC) No. 1881/2006 and subsequent amendments as concerns the maximum level admitted of the following contaminants:
      1. Aflatoxin B1
      2. Aflatoxins B1 + B2 + G1 + G2
      3. Ochratoxin
      4. Melamine

    REGULATION (EC) No. 1933/2015 amending regulation (EC) No. 1881/2006 as regards maximum levels for polycyclic arom atic hydrocarbons, in particular:

    1. Maximum level of 10 ug/kg of benzo(a)pyrene
    2. 50 ug/kg for the sum of PAH4 (benzo(a)pyrene, chrysene, benz(a)anthracene and benzo(b)fluoranthene) in food supplements.
    • Nanomaterial Statement
      According to the definition of “nanomaterials" of the EU Regulation (EU) No. 1169/2011 of the European parliament and of the council of 25 October 2011 on the provision of food information to consumers, we hereby attest that no nanomaterials are used in the formulation or in the packaging material of the product.
    • Anti-Doping Statement
      As per the list of 2017 and subsequent amendments of the world anti-doping agency, the ingredient is not a doping substance and not a combination of doping substances. The ingredient does not contain any doping substance. The ingredient does not result from a doping substance.
    • Expected Usage
      The expected usage ofthis product is its incorporation as an ingredientin the food industryor the pharmaceutical industry.
    Allergen Decleration EU
    Allergens Direct Incorporation Cross Contamination
      Presence on the production line Presence on the production workshop Presence on the production factory
    Cereals containing gluten (1) and
    products thereof
    NO NO NO NO
    Crustaceans and products
    there of
    NO NO NO NO
    Eggs and products thereof NO NO NO NO
    Fish and products thereof (2) NO NO NO NO
    Peanuts and products there of NO NO NO NO
    Soybeans and products there of
    (3)
    NO NO NO NO
    Milk and products thereof
    (including lactose) (4)
    NO NO NO NO
    Nuts (5) or products thereof NO NO NO NO
    Celery and products there of NO NO NO NO
    Mustard and products there of NO NO NO NO
    Sesame seeds and products
    there of
    NO NO NO NO
    Sulfur dioxide and sulphites at
    concentrations of more than 10
    mg/kg or 10 mg/l expressed as
    SO2
    NO NO NO NO
    Lupines and products thereof NO NO NO NO
    Mollusk and product thereof NO NO NO NO

     

    (1) Cereals which contain gluten (i.e.w heat, rye, barley, oats, spelt, kamut or their hybridized strains) except: w heat-based glucose syrups including dextrose, wheat-based maltodextrins, glucose syrups based on barley, cereals used for making distillates or ethyl alcohol of agricultural origin for spirit drinks and other alcoholic beverages.
    (2) Except: fish gelatine used as carrier for vitamin or carotenoid preparations, fish gelatine or singlass used as fining ag ent in beer and wine.
    (3) Except fully refined soybean oil and fat, natural mixed tocopheols (E306), natural D-alpha tocopherol, natural D-alpha tocopherol acetate, natural D-alpha tocopherol succinate from soybean sources;vegetable oils derived phytosterols and phytosterolesters from soybean sources; plant stanol es ter producted from vegetable oil sterols from soybean sources.
    (4) Except when used for making distillates or ethyl alcohol of agricultural origin for spirit drinks and other alcoholic beverages, lac tito.
    (5) Almond (Amydalus communis L.) hazelnuts (Corylus avellana), walnut (Juglans regia), cashew (Anacardium occidentale), pecan nuts (Carya illinaiesis), brazil nut (Bertholletia excelsa), pistachio nut (Pistacia vera), macadamia nut and queensland nut
    (Macadamia terniflora) and products thereof, except nuts used for making distillates or ethyl alcohol of agricultural origin for spirit drinks and other alcoholic beverages

    In accordance with the directive 1169/2011 EC.

    GMO Declaration
      Present GM-Origin
    Cotton No Not-Applicable
    Maize No Not-Applicable
    Potato No Not-Applicable
    Rape No Not-Applicable
    Soya No Not-Applicable
    Sugarbeet No Not-Applicable
    Tomato No Not-Applicable
    Wheat No Not-Applicable

    The following ingredients produced from genetically modified organisms are present in the product: None
    In accordance with the regulation (EC) No 1829/2003 and (EC) No 1830/2003 of the European Parliament

    Technical Details & Test Data

    Plant Information
    • Scientific name : Inonotus obliquus (Ach. ex Pers.) Pilat
    • Synonyms : Polyporus obliquus (Ach. ex Pers.) Fr. Fomes obliquus (Ach. ex Pers.) Cooke
    • Botanical family : Hymenochaetaceae
    • Common names : Chaga, birch conk
    • Geographical origin : Russian Federation, Siberia
       

    Harvest

    Period (month/s or season) Spring / autumn
    Method (manual/mechanical) Manual
    Used part Sclerotium
    Type of culture (wild/cultivated) Wild
    Plant growth stage Sclerotium diameter at least 20 cm, the age is at least 7-10 years

     

    After Harvest

    Crushed Yes
    Cleaned Yes
    Dried Electric oven

     

    Additional Information

    Treatments before/after harvest No / No
    Identification Botanical and chemical (Pharm. Russian Federation "Chaga")
    Storage In dry and cool well-ventilated place away from light
    Extraction Details
    Extraction method Solvent extraction
    Solvent(s) Water
    Drying method Spray
    Carrier/ excipient No
    Ratio 8:1
    Product Flow Chart

    Vitaforest Chaga Mushroom Native Dry Extract - Product Flow Chart

    Manufacturing Process

    We have built a full production cycle - from the search and collection of raw materials, the manufacture of the product to the delivery of the order to the client's territory. This guarantees you stable prices, stable quality and continuous deliveries. We focus on the needs of our customers and, upon request, carry out additional analyzes, develop the necessary documentation. and we produce extracts and powders with the characteristics you need.

    Verification : We check raw materials and final products with the help of laboratory tests at every stage from raw material preparation to finished extracts and powders. The supplied products comply with the EU safety and quality standards.

    Safety & Health

    Influence
    General Effects on Body
    • It is effective in oncological diseases, especially affecting organs with abundant blood supply - lungs, stomach, as well as in cases excluding radiation therapy and surgical methods.
    • It has an antispasmodic effect (relieves spasms of smooth muscles of internal organs)
    • It protects liver cells from toxic damage
    • It has an immunomodulatory effect (increases immunity), chaga increases the body's resistance to infectious diseases
    • It has a diuretic effect (diuretic)
    • It has anti-inflammatory properties
    For Female Health
    • It is used to treat tumors of the uterus and ovaries improves insomnia performance
    • It is used for infertility treatment and treatment of mastopathy
    For Male Health
    • It is used to improve potency
    Impact on the Circulatory System
    • It lowers blood sugar
    • It lowers arterial and venous pressure, reduces the pulse rate, regulates the activity of the cardiovascular system
    • It stimulates blood formation (increases the level of leukocytes - cells responsible for immunity)
    Gastrointestinal Tract
    • It normalizes the activity of the gastrointestinal tract and intestinal microflora
    • It contributes to the scarring of gastric and duodenal ulcers
    Effect on the Skin
    • It is used to treat skin diseases (such as psoriasis)
    • When it is used externally, chaga exhibits an anti-inflammatory, healing and analgesic effect, protects the skin from the harmful effects of the external environment, including fungal and viral infections, relieves swelling and contributes to the restoration of healthy skin.
    Indications & Contrindications

    Indications

    • Oncological diseases
    • Reduced immunity
    • Mastopathy
    • Gastrointestinal diseases
    • Microflora disorders
    • Psoriasis and other skin diseases

    Contrindications

    • Colitis
    • Desentery
    • Pregnancy
    • Penicillin antibiotic treatment

    Packaging & Availability

    Packaging Information
    • Ingredients are packed into double bags to avoid moisture condensation. During shipment bags are stored into double-double carton boxes.
    • 10 kg/carton box

    Storage & Handling

    Shelf Life
    3 years
    Storage and Shelf Life

    Stored in a well-closed container in cool and dry place, keep away from direct strong light and heat. Not less than 2 years when properly stored (see COA).